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Abstract
Background: Zymomonas mobilis produces near theoretical yields of ethanol and recombinant strains are candidate 
industrial microorganisms. To date, few studies have examined its responses to various stresses at the gene level. Hfq is 
a conserved bacterial member of the Sm-like family of RNA-binding proteins, coordinating a broad array of responses 
including multiple stress responses. In a previous study, we observed Z. mobilis ZM4 gene ZMO0347 showed higher 
expression under anaerobic, stationary phase compared to that of aerobic, stationary conditions.
Results: We generated a Z. mobilis hfq insertion mutant AcRIM0347 in an acetate tolerant strain (AcR) background and 
investigated its role in model lignocellulosic pretreatment inhibitors including acetate, vanillin, furfural and 
hydroxymethylfurfural (HMF). Saccharomyces cerevisiae Lsm protein (Hfq homologue) mutants and Lsm protein 
overexpression strains were also assayed for their inhibitor phenotypes. Our results indicated that all the pretreatment 
inhibitors tested in this study had a detrimental effect on both Z. mobilis and S. cerevisiae, and vanillin had the most 
inhibitory effect followed by furfural and then HMF for both Z. mobilis and S. cerevisiae. AcRIM0347 was more sensitive 
than the parental strain to the inhibitors and had an increased lag phase duration and/or slower growth depending 
upon the conditions. The hfq mutation in AcRIM0347 was complemented partially by trans-acting hfq gene expression. 
We also assayed growth phenotypes for S. cerevisiae Lsm protein mutant and overexpression phenotypes. Lsm1, 6, and 
7 mutants showed reduced tolerance to acetate and other pretreatment inhibitors. S. cerevisiae Lsm protein 
overexpression strains showed increased acetate and HMF resistance as compared to the wild-type, while the 
overexpression strains showed greater inhibition under vanillin stress conditions.
Conclusions: We have shown the utility of the pKNOCK suicide plasmid for mutant construction in Z. mobilis, and 
constructed a Gateway compatible expression plasmid for use in Z. mobilis for the first time. We have also used genetics 
to show Z. mobilis Hfq and S. cerevisiae Lsm proteins play important roles in resisting multiple, important industrially 
relevant inhibitors. The conserved nature of this global regulator offers the potential to apply insights from these 
fundamental studies for further industrial strain development.
Background
Biomass-based bioenergy is crucial to meet national goals
of making cellulosic ethanol cost-competitive with gaso-
line. A core challenge in fermenting cellulosic material to
ethanol is the recalcitrance of biomass to breakdown.
Severe biomass pretreatments are therefore required to
release the sugars, which along with by-products of fer-
mentation can create inhibitors including sugar degrada-
tion products such as furfural and hydroxymethylfurfural
(HMF); weak acids such as acetic, formic, and levulinic
acids; lignin degradation products such as the substituted
phenolics vanillin and lignin monomers [1]. In addition,
the metabolic byproducts such as ethanol, lactate, and
acetate also influence the fermentation by slowing and
potentially stopping the fermentation prematurely. The
increased lag phase and slower growth increases the etha-
nol cost due to both ethanol production rate and total
ethanol yield decreases [2,3]. One approach to overcome
the issue of inhibition caused by pretreatment processes
is to remove the inhibitor after pretreatment from the
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biomass physically or chemically, which requires extra
equipment and time leading to increased costs. A second
approach utilizes inhibitor tolerant microorganisms for
efficient fermentation of lignocellulosic material to etha-
nol and their utility is considered an industrial require-
ment [1].
Z. mobilis are Gram-negative facultative anaerobic bac-
teria with a number of desirable industrial characteristics,
such as high-specific productivity and ethanol yield,
unique anaerobic use of the Entner-Doudoroff pathway
that results in low cell mass formation, high ethanol toler-
ance (12%), pH 3.5-7.5 range for ethanol production and
has a generally regarded as safe (GRAS) status [4-9]. Z.
mobilis strains have been engineered to ferment pentose
sugars such as xylose, arabinose and other substrates with
high yields, but a low tolerance to acetic acid and
decreased ethanol tolerance have been reported in
recombinant strains [4,10-12]. Z. mobilis mutant strains
tolerant to a pretreatment inhibitor such as acetate have
been generated by chemical mutagenesis with N-methyl
N'-nitro N-nitrosoguanidine and selection in continuous
culture with a progressively increasing concentration of
sodium acetate in the medium feed [13]. AcR is capable of
efficient ethanol production in the presence of 20 g/L
NaAc, while the parent ZM4 is inhibited significantly
above 12 g/L NaAc under the same conditions [13].
We have investigated Z. mobilis ZM4 gene expression
and metabolomic profiles during aerobic and anaerobic
conditions and found that aerobic, stationary phase con-
ditions produced a number of inhibitory secondary
metabolites [14] and the expression of a putative hfq gene
ZMO0347 was greater in anaerobic stationary phase
c o m p a r e d  t o  t h a t  o f  a e r o b i c  c o n d i t i o n s  [ 1 4 ] .  H f q  i s  a
global regulator that acts as an RNA chaperone and is
involved in coordinating regulatory responses to multiple
stresses [15-18]. However, little is known about Z. mobilis
Hfq.
The aim of this study was to investigate the role of a
putative  hfq  gene ZMO0347 on multiple pretreatment
inhibitor tolerances. Z. mobilis genetic modification has
been reported previously with the sacC, adhB, and ndh
targets for mutagenesis [19-21]. However, the existence of
native plasmids [22,23] and intrinsic antibiotic resistance
impedes the use of many broad-host-range plasmids
[22,24,25]. In this work, we identified appropriate antibi-
otics for Z. mobilis genetic studies, created an expression
plasmid vector, and utilized the pKNOCK-Km suicide
plasmid [26] to create an hfq mutant in Z. mobilis acetate
tolerant strain AcR. We demonstrate that the Z. mobilis
hfq is important for Z. mobilis tolerance to several classes
of lignocellulosic pretreatment inhibitors.
Hfq is part of an ancient family of proteins termed Sm
and Sm-like (Lsm) proteins that are conserved among
bacteria, archaea, and eukaryotes such as yeast S. cerevi-
siae [16,27]. Seven core yeast Sm proteins form a hetero-
heptameric ring with a small central hole and are
essential [28]. Eight Lsm proteins (LSM1, LSM2, LSM3,
LSM4, LSM5, LSM6, LSM7, and LSM8) in S. cerevisiae
form two different heteroheptameric rings containing
either Lsm1p or Lsm8p with common Lsm2p-7p compo-
nents [28]. The complex containing Lsm2-8p localizes to
the nucleus and is involved in nuclear RNA processing,
and the complex containing Lsm1-7p contributes to cyto-
plasmic RNA processing [28,29]. In addition, LSM9
(MAK31) has also been reported to contain a Sm domain,
as well as other proteins such as LSM12 (YHR121W),
LSM13 (SCD6, YPR129W), and LSM16 (EDC3,
YEL015W) [29]. In this study, we also show that S. cerevi-
siae Lsm1, 6, and 7 proteins contribute to yeast pretreat-
ment inhibitor tolerance.
Results
Bioinformatics analysis of a putative Z. mobilis Hfq and 
related S. cerevisiae proteins
To assess whether Z. mobilis ZMO0347 was similar to
other known members of the Hfq family of regulators, the
ZMO0347 protein sequence was used in a BlastP analysis
[30]. The BlastP result indicates that ZMO0347 is similar
to the E. coli global regulator Hfq protein (60% sequence
identity), and to eukaryotic homologues such as Sm or
Lsm proteins exist in other microorganisms like S. cerevi-
siae  (Additional file 1). These analyses suggest that
ZMO0347 is likely an Hfq regulator family protein in Z.
mobilis. Interestingly, the Z. mobilis ZMO0347 (Hfq) pro-
tein possesses two Sm-like family domains, two intra-
hexamer interaction sites, two inter-hexamer interaction
sites, two nucleotide binding pockets, and has an extra
Sm-like domain near the C-terminus (Additional file 1A)
which is unlike most of the bacterial Hfq protein
sequences that have only one Sm-like domain (Additional
file 1). S. cerevisiae has nineteen proteins with a Sm or
Sm-like domain, and although examples like Sm protein
(SmB) and Lsm protein (Lsm1) (Additional file 1C, D,
respectively) contain Sm-like domains, significant
sequence similarity was not observed by BlastP analysis.
Z. mobilis AcR strain hfq mutant construction and 
complementation
Intrinsic  Z. mobilis antibiotic resistance has been
reported previously [22,25], which restricts the use of the
available broad-host-range plasmids. We tested the anti-
biotic sensitivities of ZM4 and AcR as an initial step for
genetic studies with these strains. Each strain was tested
against the following antibiotics; chloramphenicol (25,
50, 100, and 200 μg/mL), gentamicin (100, 200, and 300
μg/mL), kanamycin (100, 200, and 300 μg/mL), strepto-
mycin (200 and 300 μg/mL), and tetracycline (25, 50, 100,
and 200 μg/mL). Each assay was conducted under aerobicYang et al. BMC Microbiology 2010, 10:135
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and anaerobic conditions and similar growth results were
observed under the respective conditions for the different
doses. Z. mobilis was tolerant to streptomycin at concen-
tration of 300 μg/mL and gentamicin at 100 μg/mL. Z.
mobilis was able to grow slightly at 100 μg/mL kanamycin
and 300 μg/mL gentamicin, and was sensitive to tetracy-
cline and chloramphenicol at concentrations above 25
μg/mL (data not shown).
We generated an hfq insertion mutant in a Z. mobilis
acetate tolerant strain (AcR) background using the
pKnock-Km suicide plasmid system [26,31], and desig-
nated it as strain AcRIM0347 (See Methods for details).
Since many mutagenesis systems use either chloram-
phenicol or kanamycin markers, tetracycline resistance
was used as an expression plasmid antibiotic marker for
new Gateway entry vector pBBR3DEST42 construction
(Additional file 2), which was then used to generate plas-
mid p42-0347 to express hfq gene ZMO0347. The nucle-
otide sequence for plasmid p42-0347 was verified by
Sanger sequencing, and the expression of hfq from plas-
mid p42-0347 in E. coli was confirmed by Western blot
analysis (data not shown). Plasmid p42-0347 was then
introduced into the wild-type strain ZM4, acetate toler-
ant mutant AcR, and hfq mutant AcRIM0347 background
by conjugation and selection. The presence of correct
p42-0347 construct in ex-conjugants was confirmed by
PCR and Sanger sequencing analysis. The oligonucle-
otide primers used to generate hfq mutant AcRIM0347
and complement hfq mutation in AcRIM0347 are listed in
Table 1.
Z. mobilis hfq contributes to pretreatment inhibitor 
tolerance
Pretreatment inhibitors had negative effects on Z.
mobilis  growth: the growth of Z. mobilis strains was
reduced in the presence of acetate, vanillin, furfural, or
HMF with increased lag phases and/or slower growth
rates and/or final bacterial cell densities depending on the
respective condition and strain (Table 2, 3; Fig. 1, 2).
Among the different forms of acetate counter-ions tested,
sodium acetate had the most inhibitory effect on wild-
type Z. mobilis growth. This was followed by potassium
acetate and ammonium acetate and sodium chloride had
the least negative influence on wild-type Z. mobilis
growth (Table 2; Fig. 1). Wild-type ZM4 growth was
completely inhibited when RM medium was amended
with 195 mM sodium acetate (Table 2; Fig. 1C) in keeping
with previous reports [13]. Among the pretreatment
inhibitors of vanillin, furfural, and HMF, vanillin had the
most inhibitory effect on Z. mobilis and HMF the least
(Table 3). Z. mobilis took longer to complete active
growth and reach the stationary phase, which was about
16, 19 or 21 h in the presence of HMF, furfural or vanillin,
respectively, compared to 11 h without any inhibitor
present in the medium (Fig. 2).
Hfq contributes to sodium and acetate ion tolerances:
although the final cell density of hfq mutant AcRIM0347
is similar to that of AcR parental strain (Table 2; Fig. 2A),
the growth rate of AcRIM0347 was reduced about one-
fifth even without any inhibitor in the RM, which indi-
cates hfq plays a central role in normal Z. mobilis physiol-
ogy. Wild-type ZM4 that contained p42-0347 was able to
grow in the presence of 195 mM sodium acetate and had
a similar growth rate and final cell density to that of ace-
tate tolerant strain AcR (Table 2; Fig. 1C). The wild-type
ZM4 was unable to grow under this condition.
The inactivation of the hfq gene in AcR decreased this
a c e t a t e  t o l e r a n t  s t r a i n ' s  r e s i s t a n c e  t o  b o t h  s o d i u m  i o n
(sodium chloride) and acetate ion (ammonium acetate
and potassium acetate) (Table 2; Fig. 1). hfq  mutant
AcRIM0347 was unable to grow in the presence of 195
mM ammonium acetate or potassium acetate (Table 2;
Fig. 1D, E). Both the growth rate and final cell density of
hfq mutant AcRIM0347 were reduced by at least a quar-
ter in the presence of 195 mM sodium chloride, and
about 60% in the presence of 195 mM sodium acetate
compared to that of the parental strain AcR (Table 2; Fig.
1B, C). The AcRIM0347 hfq mutation was complemented
by the introduction of an hfq-expressing plasmid (p42-
0347) into the strain. The complemented mutant strain
recovered at least half of the parental strains growth rate
and 70% of its final cell density in the presence of 195 mM
acetate ion (whether as sodium, ammonium or potassium
acetate) (Table 2; Fig. 1).
Hfq contributes to vanillin, furfural and HMF toler-
ances: AcRIM0347 growth rates were lower than that of
ZM4 and AcR under all conditions tests, and except for
growth in RM broth (Table 3; Fig. 2). AcRIM0347 also
achieved lower final cell densities compared to ZM4 and
AcR (Table 3; Fig. 2). When AcRIM0347 was provided
functional  Z. mobilis Hfq via p42-0347, growth rates
under all conditions were largely unchanged (Table 3).
However, shorter lag phases were observed for
AcRIM0347 (p42-0347) grown with vanillin, furfural or
HMF and increases in final cell densities were also
observed under these conditions (Table 3; Fig. 2). These
data indicate that hfq is important for optimal Z. mobilis
growth and its ability to resist furfural, HMF and vanillin
toxicity.
Yeast Lsm proteins contribute to pretreatment inhibitor 
tolerance
Lsm protein and yeast tolerance to sodium and acetate ions
S. cerevisiae Sm and Sm-like (Lsm) proteins are similar to
Z. mobilis Hfq at the level of protein sequence (Addi-
tional file 1). Growth of yeast Lsm deletion mutants andYang et al. BMC Microbiology 2010, 10:135
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Table 1: Bacterial strains, plasmids and primers used in this study
Strain, plasmid, or primer Genotype, phenotype, or sequence of primer 
(5' to 3')
Reference
E. coli
K-12 K-12 MG1655 Wild-type strain
DH5α F- ψ80dlacZΔM15 Δ(lacZYA-argF) U169 recA1 
endA1 hsdR17(rk
-, mk
+) phoA supE44 λ- thi-1 
gyrA96 relA1
Novagen
DB3.1 F- gyrA462 endA1Δ(sr1-recA) mcrB mrr hsdS20(rB
-, 
mB
-) supE44 ara-14 galK2 lacY1 proA2 rpsL20(SmR) 
xyl-5λ-leu mtl1
Invitrogen
WM3064 thrB1004 pro thi rpsL hsdS lacZΔM15 RP4-1360 
Δ(araBAD)567 ΔdapA1341::[erm pir]
W. Metcalf
BL21(DE3) F- ompT hsdSB(rB-mB-) gal dcm (DE3) Invitrogen
Z. mobilis
ZM4 ATCC31821 ATCC
AcR ZM4 acetate tolerant strain generated by random 
mutagenesis
[13]
AcRIM0347 hfq::pKm-0347, insertional mutant of AcR hfq 
gene ZMO0347
This study
AcRIM0347 (p42-0347) AcRIM0347 containing plasmid p42-0347 This study
ZM4(p42-0347) ZM4 containing plasmid p42-0347 This study
AcR (p42-0347) AcR containing plasmid p42-0347 This study
S. cerevisiae
BY4741 MATa his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 - s288c 
background
Open Biosystems
YSC1021-554440 Yeast: Yeast Knock Out Strain (YKO_LSM1)
Clone Id: 1301; Accession: YJL124C (Lsm1)
Open Biosystems
YSC1021-552226 Yeast: Yeast Knock Out Strain (YKO_LSM6)
Clone Id: 4214; Accession: YDR378C (Lsm6)
Open Biosystems
YSC1021-556031 Yeast: Yeast Knock Out Strain (YKO_LSM7)
Clone Id: 7383; Accession: YNL147W (Lsm7)
Open Biosystems
YSC1021-552677 Yeast: Yeast Knock Out Strain (YKO_LSM9)
Clone Id: 3501; Accession: YCR020C-A (Mak31P, 
Lsm9)
Open Biosystems
YSC1021-552563 Yeast: Yeast Knock Out Strain (YKO_LSM12)
Clone Id: 1949; Accession: YHR121W (Lsm12)
Open Biosystems
YSC1021-553518 Yeast: Yeast Knock Out Strain (YKO_LSM13)
Clone Id: 5544; Accession: YPR129W (Lsm13)
Open Biosystems
YSC1021-552280 Yeast: Yeast Knock Out Strain (YKO_LSM16)
Clone Id: 255; Accession: YEL015W (Lsm16)
Open Biosystems
YSC4515-98807049 Yeast GST-Tagged Strain (GST_LSM1)
Clone Id: YJL124C; Accession: YJL124C (lsm1)
Open Biosystems
YSC4515-98811389 Yeast GST-Tagged Strain (GST_LSM6)
Clone Id: YDR378C; Accession: YDR378C (Lsm6)
Open Biosystems
YSC4515-98805426 Yeast GST-Tagged Strain (GST_LSM9)
Clone Id: YCR020C-A; Accession: YCR020C-A 
(Mak31P, Lsm9)
Open Biosystems
YSC4515-98806813 Yeast GST-Tagged Strain (GST_LSM12)
Clone Id: YHR121W; Accession: YHR121W (Lsm12)
Open BiosystemsYang et al. BMC Microbiology 2010, 10:135
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Lsm over-expressing strains in 305 mM ammonium ace-
tate, potassium acetate, or sodium acetate was assessed to
test whether S. cerevisiae Lsm proteins and ZM4 Hfq had
functionally similar roles. These studies included seven
Lsm deletion mutants affecting three Lsm heteroheptam-
eric ring components (Lsm1, Lsm6, Lsm7) and four other
Lsm proteins containing an Sm domain (Lsm9, Lsm12,
Lsm13, Lsm16), as well as six Lsm protein over-express-
ing strains (Lsm1, Lsm6, Lsm9, Lsm12, Lsm13, Lsm16).
We present growth data for those genes that gave clear
phenotypic differences for the sake of clarity and a list of
all strains tested in this study can be found in Table 1.
Growth differences between the Lsm mutants and yeast
wild-type BY4741 in the CM broth without the addition
of acetate or with 305 mM NaCl were not observed
(Additional file 3A, B, respectively). S. cerevisiae Lsm
proteins involved in RNA processing ring complex for-
mation (Lsm1, 6, 7), especially Lsm6, played a role in ace-
tate tolerance (Additional file 3C-E, K-M). Lsm protein
deletion mutants Lsm1, 6, and 7 showed decreased ace-
tate tolerance compared to the wild-type control strain,
especially in early growth stages for acetate with sodium,
ammonium and potassium counter-ions (Additional file
3C-E). The Lsm overexpression strains grew similarly to
wild-type BY4741 without the addition of acetate or with
305 mM NaCl (Additional file 3I, J), but each of the Lsm
protein overexpression strains showed enhanced acetate
tolerance compared to the wild-type strain with sodium,
ammonium or potassium counter-ions (Additional file
3K-M).
Lsm proteins and yeast tolerance to vanillin, furfural and HMF
the effect of Lsm proteins on S. cerevisiae tolerance to
pretreatment inhibitors vanillin, furfural, and HMF was
also investigated using the seven Lsm deletion mutants
and six Lsm overexpression strains described above. Each
yeast deletion mutant and each overexpression strain
showed similar growth profiles compared to wild-type
strain BY4741 in the absence of inhibitors (Additional file
YSC4515-98808930 Yeast GST-Tagged Strain (GST_LSM13)
Clone Id: YPR129W; Accession: YPR129W (Lsm13)
Open Biosystems
YSC4515-98809076 Yeast GST-Tagged Strain (GST_LSM16)
Clone Id: YEL015W; Accession: YEL015W (Lsm16)
Open Biosystems
Plasmids
pKNOCK-Km Kmr, mob, broad host range suicide cloning 
vector, 1.8 kb
[26]
pET-DEST42 Apr, Cmr, C-terminal 6×His and V5 epitope Invitrogen
pDONR221 Kmr, gateway entry vector Gmr, N-terminal GST Invitrogen
pBBR1MCS-3 Tcr, mob, broad host range cloning vector [36]
pBBR3DEST42 Cmr Tcr, C-terminal 6×His and V5 epitope This study
pKm-0347 pKnock-Km containing 262-bp hfq internal 
fragment for insertional mutant construction
This study
p42-0347 pBBR3DEST42 containing ZM4 gene ZMO0347 This study
PCR Primers
hfq_MF cggagagatggtcagtcaca 262-bp
hfq_MR ttcttgctgctgcataatcg
hfq_CF ggggacaagtttgtacaaaaaagcaggcttcgaaggagatag
aATGGCCGAAAAGGTCAACAATC
483-bp
hfq_CR ggggaccactttgtacaagaaagctgggtcATCCTCGTCTC
GGCTTTCTG
hfq_OCF Caaagcttgagctcgaattcatttttgccgtggtagttgc 1050-bp
hfq_OCR caggtacctctagaattcaccactcaatcctcgtctcg
hfq_MF and hfq_MR are primers used for insertional mutant construction using pKnock mutagenesis system. Hfq_OCF and Hfq_OCR are 
primers for mutant confirmation. Hfq_CF and Hfq_CR are primers used to clone the hfq gene into low copy number Gate-Way compatible 
plasmid pBBR3DEST42 for complementation, which results in a plasmid called p42-0347.
Table 1: Bacterial strains, plasmids and primers used in this study (Continued)Yang et al. BMC Microbiology 2010, 10:135
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3A; I). Deletion mutants for Lsm1, 6 and 7 proteins were
u n a b l e  t o  g r o w  o r  s h o w e d  e x t e n d ed  l a g  p h a s e s  be f o r e
recovery from the inhibitory effects of pretreatment
inhibitors (Additional file 3F-H). Overexpression of Lsm
proteins provided a slight growth advantage in the pres-
ence of 1.5 g/L HMF and furfural (Additional file 3O-P).
However, a detrimental effect on growth was observed
for overexpression strains when cultured in the presence
of 0.75 g/L vanillin (Additional file 3N). The data indi-
cated that Lsm proteins Lsm1, 6, and 7 especially Lsm6,
which are the components of yeast RNA processing ring
complex, play a role in tolerance to the model inhibitors
used in this study.
Discussion
A previous study indicated that Z. mobilis ZM4 hfq was
less abundant in aerobic, stationary phase fermentations
compared to the equivalent anaerobic condition and that
rpoH was induced under the aerobic condition [14]. The
role of Z. mobilis regulators like Hfq and extent of cross
talk between regulatory networks remains to be eluci-
dated. This study indicated that hfq also plays a role in Z.
mobilis resistance to both acetate (sodium acetate, potas-
sium acetate, or ammonium acetate) and sodium ions
(sodium chloride and sodium acetate) (Table 2; Fig. 1). A
recent study has identified that nhaA  overexpression
(encoding a sodium-proton antiporter) conferred the
previously reported AcR (sodium acetate tolerant)
mutant phenotype [32]. Constitutive nhaA over-expres-
sion in strain AcRIM0347 (hfq-) is a likely possibility for it
being unable to survive with 195 mM ammonium acetate
or potassium acetate, while the same concentration of
sodium acetate only partially repressed its growth. hfq or
nhaA each contribute to sodium acetate tolerance (Table
2; Fig. 1C) [32], but there is no additive benefit for
increased inhibitor tolerance for hfq  and  nhaA if both
were over-expressed at the same time (data not shown).
In addition, the overexpression of nhaA gene in Z. mobi-
lis  had no advantage over other physiological stress
responses for model pretreatment inhibitors such as van-
illin, furfural, and HMF [32]. While Z. mobilis hfq con-
tributes to the tolerance of these inhibitors as shown by
increased hfq mutant AcRIM0347 lag phases and slower
growth rates during early logarithmic growth phase com-
pared to AcR strain (Fig. 2). These separate studies indi-
cate there may often be more than one pathway for
industrial strain development.
The majority of proteins similar to Z. mobilis Hfq con-
tained one Sm-like superfamily domain (Additional file
3), with the exception of those from six other species also
Table 2: Growth rate and final cell density of different Z. mobilis strains in the absence or presence of different sodium and 
acetate ions.
ZM4 AcR AcRIM0347 AcRIM0347 
(p42-0347)
ZM4 
(p42-0347)
Growth rate 
(hour-1)
RM 0.42 ± 0.01 0.39 ± 0.01 0.32 ± 0.003 0.33 ± 0.002 0.38 ± 0.003
RM (NaCl) 0.24 ± 0.008 0.29 ± 0.005 0.21 ± 0.008 0.22 ± 0.009 0.25 ± 0.008
RM (NH4OAc) 0.20 ± 0.008 0.19 ± 0.005 NA 0.22 ± 0.002 0.19 ± 0.007
RM (Kac) 0.15 ± 0.004 0.12 ± 0.000 NA 0.09 ± 0.003 0.12 ± 0.006
RM (NaAc) NA 0.29 ± 0.04 0.12 ± 0.004 0.16 ± 0.002 0.27 ± 0.004
Final Cell Density 
(OD600 nm)
RM 0.95 ± 0.006 1.01 ± 0.006 0.94 ± 0.004 0.92 ± 0.002 1.02 ± 0.004
RM (NaCl) 0.73 ± 0.01 0.96 ± 0.01 0.73 ± 0.03 0.72 ± 0.02 0.84 ± 0.01
RM (NH4OAc) 0.43 ± 0.01 0.42 ± 0.006 NA 0.32 ± 0.007 0.37 ± 0.008
RM (Kac) 0.42 ± 0.002 0.40 ± 0.000 NA 0.28 ± 0.007 0.34 ± 0.004
RM (NaAc) NA 0.63 ± 0.02 0.25 ± 0.001 0.45 ± 0.002 0.59 ± 0.002
"NA" indicates that the data are not available due to the lack of growth in that condition. The concentration for all the chemicals (NaCl, 
NH4OAc, KAc, NaAc) supplemented into the RM is 195 mM. NaCl: sodium chloride, NH4OAc: ammonium acetate, KAc: potassium acetate, 
NaAc: sodium acetate. Strains included in this study are: ZM4: Zymomonas mobilis ZM4 wild-type; AcR: previously described ZM4 acetate 
tolerant mutant; ZM4 (p42-0347): ZM4 containing a gateway plasmid p42-0347 to express ZM4 gene ZMO0347; AcRIM0347: AcR insertional 
mutant of ZMO0347; AcRIM0347 (p42-0347): AcRIM0347 containing gateway plasmid p42-0347. This experiment has been repeated at least 
three times with similar result. Duplicate biological replicates were used for each condition.Yang et al. BMC Microbiology 2010, 10:135
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within the Sphingomonadales. Future structural studies
are required to define the role for Z. mobilis and other
microorganisms with two Sm-like family domains, to elu-
cidate Hfq subunit interactions, and to test whether only
three Hfq proteins would be needed for Z. mobilis to
form the active homo-hexameric ring structure.
We assayed growth phenotypes for S. cerevisiae Lsm
protein mutant and overexpression phenotypes. Lsm1, 6,
and 7 mutants showed reduced tolerance to acetate and
other pretreatment inhibitors (Additional file 3). The S.
cerevisiae  Lsm over-expression studies showed these
strains had increased acetate and HMF resistance com-
pared to the wild-type strain, while the overexpression
strains were more inhibited under vanillin stress condi-
tions (Additional file 3). The conserved nature of Sm-like
proteins, the involvement of ZM4 Hfq and S. cerevisiae
Sm-like proteins in pretreatment inhibitor tolerance
offers the possibility of manipulating hfq and members of
the Lsm family for strain development purposes.
Conclusions
We created a plasmid for gene expression and mutation
complementation in Z. mobilis and used the pKnock sys-
tem to create an hfq mutant in Z. mobilis acetate tolerant
strain AcR. We showed that Z. mobilis hfq played a role in
tolerance to multiple biomass pretreatment inhibitors
including acetate, vanillin, furfural, and HMF. In addition,
Hfq homologues of yeast Lsm proteins Lsm1, 6, and 7
involving in the RNA processing heteroheptameric ring
complex formation, especially Lsm6, contribute to multi-
ple pretreatment inhibitor tolerance in S. cerevisiae.
However, further studies such as systems biology studies
and ChIP-Seq are required to elucidate the hfq  stress
response regulon in Z. mobilis and the yeast inhibitor tol-
erance genes affected by the RNA processing Lsm com-
plexes.
Methods
Strains and culture conditions
Bacterial strains and plasmids used in this study are listed
in Table 1. E. coli strains were cultured using Luria-Ber-
tani (LB) broth or agar plates. E. coli WM3064 was sup-
plemented with 100 μg/mL diaminopimelic acid (DAP).
Z. mobilis ZM4 was obtained from the American Type
Culture Collection (ATCC 31821) and the Z. mobilis ace-
tate tolerant strain AcR has been described previously
[13]. ZM4 and AcR were cultured in RM medium (Glu-
cose, 20.0 g/L; Yeast Extract, 10.0 g/L; KH2PO4, 2.0 g/L,
pH5.0) at 30°C.
S. cerevisiae wild-type, deletion mutant and GST-fusion
ORF overexpression strains were obtained through Open
Biosystems (Huntsville, AL). S. cerevisiae strains were
cultured in CM medium with 2% glucose for wild-type
and S. cerevisiae deletion mutants. CM medium with 2%
glucose minus uracil was used for S. cerevisiae GST-over
expressing strains, and 2% galactose was used to induce
the GST-fusion strains. CM broth with glucose and CM
broth with glucose minus uracil were purchased from
Teknova Inc. (Hollister, CA) (C8000 and C8140 respec-
tively).
Table 3: Growth rate and final cell density of different Z. mobilis strains in the absence or presence of different 
pretreatment inhibitors.
ZM4 AcR AcRIM0347 AcRIM0347(p42-
0347)
Growth rate 
(hour-1)
RM 0.48 ± 0.03 0.46 ± 0.003 0.35 ± 0.004 0.32 ± 0.003
HMF 0.36 ± 0.02 0.35 ± 0.01 0.19 ± 0.02 0.22 ± 0.001
Furfural 0.31 ± 0.01 0.30 ± 0.005 0.19 ± 0.03 0.20 ± 0.01
Vanillin 0.26 ± 0.001 0.26 ± 0.01 0.20 ± 0.006 0.20 ± 0.003
Final Cell Density 
(OD600 nm)
RM 0.91 ± 0.01 0.98 ± 0.006 0.95 ± 0.003 0.92 ± 0.006
HMF 0.93 ± 0.003 0.96 ± 0.006 0.67 ± 0.03 0.78 ± 0.02
Furfural 0.88 ± 0.006 0.89 ± 0.009 0.67 ± 0.001 0.80 ± 0.02
Vanillin 0.69 ± 0.006 0.71 ± 0.01 0.66 ± 0.01 0.70 ± 0.01
The concentration for the inhibitor supplemented into the RM is: HMF: 0.75 g/L, furfural, or vanillin: 1 g/L. Strains included in this study are: 
ZM4: Zymomonas mobilis ZM4 wild-type; AcR: previously described ZM4 acetate tolerant mutant; AcRIM0347: AcR insertional mutant of 
ZMO0347; AcRIM0347 (p42-0347): AcRIM0347 containing gateway plasmid p42-0347. This experiment has been repeated at least three times 
with similar result. Duplicate biological replicates were used for each condition.Yang et al. BMC Microbiology 2010, 10:135
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Figure 1 Hfq contributes to Z. mobilis acetate tolerance. Z. mobilis strains were grown in RM (pH5.0) overnight, 5-μL culture were then transferred 
into 250-μL RM media in the Bioscreen plate. The growth differences of different strains were monitored by Bioscreen (Growth Curves USA, NJ) under 
anaerobic conditions; in RM, pH 5.0 (A), RM with 195 mM NaCl, pH 5.0 (B), 195 mM NaAc, pH 5.0 (C), 195 mM NH4OAc, pH 5.0 (D), or 195 mM KAc, pH 
5.0 (E). Strains included in this study are: ZM4: Zymomonas mobilis ZM4 wild-type; AcR: previously described ZM4 acetate tolerant mutant; ZM4 (p42-
0347): ZM4 containing a gateway plasmid p42-0347 to express ZM4 gene ZMO0347; AcRIM0347: AcR insertional mutant of ZMO0347; AcRIM0347 
(p42-0347): AcRIM0347 containing gateway plasmid p42-0347. This experiment has been repeated at least three times with similar result. Duplicate 
biological replicates were used for each condition.
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Plasmid-containing strains were routinely grown with
antibiotics at the following concentrations (μg/mL): kana-
mycin, 50 for E. coli and 200 for ZM4; tetracycline, 10 for
E. coli and 20 for ZM4; gentamicin, 10 for E. coli; and
G418, 200 for S. cerevisiae YKO deletion mutants. Bacte-
rial growth was monitored using the Bioscreen C auto-
mated microbiology growth curve analysis system using
600nm filter (Growth Curves USA, Piscataway, NJ).
PCR and DNA manipulations
Genomic DNA from Z. mobilis was isolated using a Wiz-
ard Genomic DNA purification kit (Promega, Madison,
WI). The QIAprep Spin Miniprep and HiSpeed Plasmid
Midi kits (Qiagen, Valencia, CA) were used for plasmid
isolation. PCR, restriction enzyme digestion, ligation,
cloning, and DNA manipulations were following stan-
dard molecular biology approaches as described previ-
ously [34] and sequencing was conducted using BigDye
Terminator v3.1 cycle sequencing chemistry (Applied
Biosystems Inc, Foster City, CA) on a 48-capillary 3730
DNA Analyzer sequencer (Applied Biosystems Inc).
AcR strain hfq insertional mutant construction
An hfq insertion mutant was created using the pKnock-
Km suicide plasmid system [26,31] in a Z. mobilis acetate
tolerant strain (AcR) background and the resulting strain
designated as AcRIM0347. Briefly, a 262-bp internal
DNA fragment of the Z. mobilis hfq gene (ZMO0347) was
amplified by PCR using primers hfq_MF and hfq_MR
(Table 1), and ligated into pKnock-Km using Fast-Link™
DNA Ligation Kit (Epicentre). The plasmid was desig-
nated as pKm-0347, which was then electroporated into
E. coli WM3064. The pKm-0347 plasmid from E. coli
WM3064 was verified by PCR and Sanger sequencing
analysis. AcR and E. coli WM3064 (pKm-0347) cells were
mixed and plated onto RM agar plates with 100 μg/mL
DAP and 50 μg/mL kanamycin for conjugation. The cells
were incubated at 30°C overnight and then subcultured
Figure 2 Z. mobilis tolerance to different classes of pretreatment inhibitors and Hfq. Z. mobilis strains were grown in RM (pH 5.0) overnight, 5-
μL culture were then transferred into 250-μL RM media in the Bioscreen plate. The growth differences of different strains were monitored by Bioscreen 
(Growth Curves USA, NJ) under anaerobic conditions in RM, pH 5.0 (A), RM with 1 g/L vanillin, pH 5.0 (B), 1 g/L furfural, pH 5.0 (C), and 1 g/L HMF, pH 
5.0 (D).
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on RM agar plates with 50 μg/mL kanamycin in the
absence of DAP. Putative conjugants were then screened
by PCR using primers hfq_OCF and hfq_OCR (Table 1).
Wild-type AcR has a 1,050-bp PCR product and hfq
mutant candidates had a 2.9-kb PCR product. Presump-
tive positive PCR products from mutant clones were con-
firmed by Sanger sequencing analysis.
Construction of a Gateway vector for ZMO0347 
overexpression and mutant complementation
Construction of hfq Gateway® entry vector and new desti-
nation vector termed pBBR3DEST42 was carried out as
previously described [35], except that we used
pBBRMCS-3 containing the tetracycline resistance cas-
sette in this study. pBBR3DEST42 was used for hfq
expression and the resulting vector designated p42-0347.
Briefly, DNA for the target gene was amplified via PCR
using AcR genomic template DNA and the hfq_CF and
hfq_CR primers (Table 1). PCR products were then
cloned into Gateway® entry clone pDONR221 using BP
Clonase II enzyme mix following the manufacturer's pro-
tocol (Invitrogen), transformed into chemically compe-
tent DH5α cells (Invitrogen), and plated onto LB with
appropriate antibiotic selection. The identity of insert
DNA was confirmed by DNA sequence analysis using the
M13 forward and reverse primers (Integrated DNA Tech-
nologies, Inc., Coralville, IA). The confirmed entry clone
vector was then recombined with destination vector
pBBR3DEST42 using LR Clonase II enzyme mix (Invitro-
gen) to create the expression vector, essentially as
described previously [35]. The resulting expression plas-
mid was designed as p42-0347. The plasmid construct
p42-0347 was confirmed by DNA sequence analysis.
ZMO0347 overexpression strain ZM4 (p42-0347) and
hfq  complemented mutant strain AcRIM0347 (p42-
02347) were generated by conjugation. Briefly, Z. mobilis
(ZM4 or AcRIM0347) cells were mixed with E. coli
WM3064 (p42-0347) cells, plated onto RM agar plates
with 100 μg/mL DAP and 10 μg/mL tetracycline for con-
jugation. The cells were incubated at 30°C overnight and
then subcultured on RM agar plates with 10 μg/mL tetra-
cycline in the absence of DAP. The tetracycline resistant
conjugants were confirmed to be correct using PCR and
Sanger sequence analysis.
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